ZEB1 and melanoma: Therapy-resistant melanomas often undergo de-differentiation, which is characterized by loss of melanocytic markers such as MLANA, TRPM1 and TYR and gain of invasive molecular markers such as c-JUN, NGFR and ZEB1 (13–16).